news
Novo Nordisk opens new research and development centre in China
24 September 2012 | By Novo Nordisk
Novo Nordisk invests an additional 100 million US dollars to expand its state-of-the-art science facilities in Beijing....
List view / Grid view
Novo Nordisk
news
Novo Nordisk ranks 4th among the world’s top 20 science employers
24 September 2012 | By Novo Nordisk
Novo Nordisk has been ranked number four on the Science 2012 Top Employer list – up from ninth place last year...
news
Novo Nordisk increased operating profit by 31% in the first half of 2012
9 August 2012 | By Novo Nordisk
Sales grew 17% driven by Victoza®, NovoRapid® and Levemir®...
news
Meeting scheduled for insulin degludec and insulin degludec/insulin aspart
18 July 2012 | By Novo Nordisk
Meeting scheduled to discuss the NDA for the ultra-long-acting insulin degludec & insulin degludec/insulin aspart....
article
Process Analytical Technology (PAT) In-Depth Focus 2012
In this PAT In-Depth Focus: Process analytics experiences in biopharmaceutical manufacturing; Correlation between powder rheology data and processability in solid dosage form manufacturing; Expert industry users of process analytical technologies for pharmaceuticals pose questions for leading vendor experts of process analytical technology...
news
NovoPen® 5 wins the red dot Best of the Best design award
2 July 2012 | By Novo Nordisk
Novo Nordisk awarded the red dot Best of the Best prize for its next-generation insulin injection pen, the NovoPen® 5...
news
Novo Nordisk to initiate phase 3 development of semaglutide
21 June 2012 | By Novo Nordisk
The decision to initiate the global phase 3 development programme for semaglutide announced...
news
Novo Nordisk puts health on the agenda in Rio
20 June 2012 | By Novo Nordisk
Novo Nordisk is hosting a side-event during the UN conference, Rio+20, on sustainable development...
news
JDRF and Novo Nordisk establish R&D collaboration in type 1 diabetes
13 June 2012 | By Novo Nordisk
Focus will be on disease-modifying immunotherapies for type 1 diabetes...
news
Global survey finds one in four type 2 diabetes patients do not take basal insulin as prescribed
12 June 2012 | By
One in four people with type 2 diabetes did not dose their long-acting (basal) insulin correctly...
news
A new study with ‘real world’ data shows greater efficacy of Victoza(R)
11 June 2012 | By Novo Nordisk
New data show that Victoza® provided greater reductions in HbA1c...
news
FDA extends regulatory review period for insulin degludec and insulin degludec/insulin aspart by three months
8 June 2012 | By Novo Nordisk
Regulatory review period extended for insulins degludec & insulin degludec/insulin aspart...
news
Novo Nordisk receives positive opinion on recombinant factor XIII from the European regulatory authorities
25 May 2012 | By Novo Nordisk
Novo Nordisk receives a positive opinion on recombinant factor XIII product (rFXIII)...
news
Novo Nordisk A/S purchases B shares worth DKK 4.2 billion from Novo A/S
2 May 2012 | By Novo Nordisk
Novo Nordisk A/S has entered into an agreement to purchase 5,100,000 B shares...
news
Novo Nordisk A/S expects to elect new chairman in 2013
27 April 2012 | By Novo Nordisk
Sten Scheibye has been elected to the Board of the Novo Nordisk Foundation...
